반응식
Cl[C:2]1[N:7]=[C:6]([NH:8][C:9]2[CH:14]=[CH:13][C:12]3[O:15][CH2:16][CH2:17][O:18][C:11]=3[CH:10]=2)[C:5]([F:19])=[CH:4][N:3]=1.Cl.N[C:22]1[C:23]([CH3:29])=[CH:24][C:25]([OH:28])=[CH:26][CH:27]=1.C([N:33](C(C)C)CC)(C)C>>[CH2:17]1[CH2:16][O:15][C:12]2[CH:13]=[CH:14][C:9]([N:8]([C:27]3[CH:22]=[C:23]([CH3:29])[CH:24]=[C:25]([OH:28])[CH:26]=3)[C:6]3[C:5]([F:19])=[CH:4][N:3]=[C:2]([NH2:33])[N:7]=3)=[CH:10][C:11]=2[O:18]1참가 물질
4
실험 절차
In like manner to the preparation of 5-fluoro-N4-(3-hydroxyphenyl)-N2-[4-(3-phenyl-1,2,4-oxadiazol-5-yl)methyleneoxyphenyl]-2,4-pyrimidinediamine, 2-chloro-N4-(3,4-ethylenedioxyphenyl)-5-fluoro-4-pyrimidineamine, 4-amino-m-cresol hydrogenchloride salt, and diisopropylethylamine were reacted to provide N4-(3,4-ethylenedioxyphenyl)-5-fluoro-N4-(3-hydroxy-5-methylphenyl)-2,4-pyrimidinediamine. 1H NMR (DMSO-d6): δ 9.06 (s, 1H), 8.94 (s, 1H), 8.11 (s, 1H), 7.86 (d, 1H, J=3.9 Hz), 7.21-7.15 (m, 2H), 7.03 (d, 1H, J=8.1 Hz), 6.59 (bd, 2H, J=8.7 Hz), 6.52 (dd, 1H, J=3.0 and 8.1 Hz), 4.17 (s, 4H), 2.05 (s, 3H); LCMS: purity: 99%; MS (m/e): 369 (MH+).
후처리
- customwere reacted
출처 및 근거
- ORD 기록
- ord-9341dd82eee04ebba41796aced798b90
- 출처 데이터셋
- uspto-grants-2016_05
- 특허 번호
- US09346765B2
연결된 노트
불러오는 중…